Neumora Therapeutics, Inc. Common Stock (NMRA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Neumora Therapeutics, Inc. Common Stock (NMRA) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

NMRA Income Statement

Neumora Therapeutics, Inc. Common Stock (NMRA) annual income statement — 6-year revenue, gross profit & net income history

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q2'22	Q1'22	Q4'21	Q3'21	Q4'20

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	8K	0	5M	0	0	0	0	0	0	166K	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-8K	0	-5M	0	0	0	0	0	0	-166K	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	-	100%	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	42.19M	52.86M	58.48M	52.7M	54.04M	70.94M	62.92M	76.65M	63.82M	60.07M	49.93M	56.86M	42.06M	39.17M	30.72M	31.31M	43.24M	26.55M	178.13M	19.53M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	12.91M	14.27M	13.81M	12.18M	15.32M	18.79M	17.01M	16.02M	15.19M	14.32M	11.07M	15.26M	9.29M	9.68M	7.2M	7.79M	8.09M	7.64M	6.66M	4.29M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	29.28M	38.6M	44.67M	40.52M	38.72M	52.15M	45.91M	60.63M	48.63M	45.76M	38.86M	41.6M	32.77M	29.48M	23.52M	23.53M	35.15M	18.91M	171.47M	15.23M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-42.19M	-52.86M	-58.48M	-57.7M	-54.04M	-70.94M	-62.92M	-76.65M	-63.82M	-60.07M	-50.1M	-56.86M	-42.06M	-39.17M	-30.72M	-31.31M	-43.24M	-26.55M	-178.13M	-19.53M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	21.93%	25.48%	7.06%	24.72%	15.33%	-18.08%	-25.59%	-34.79%	-51.73%	-53.38%	-63.1%	-	-34.32%	9.41%	-15.71%	-	-	-35.94%	-	-
EBITDA	-42.18M	-52.86M	-58.47M	-57.68M	-54.02M	-70.78M	-62.77M	-76.49M	-63.66M	-59.92M	-49.93M	-56.69M	-41.89M	-39.01M	-30.57M	-31.16M	-43.09M	-26.42M	-177.98M	-19.46M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	21.91%	25.32%	6.84%	24.6%	15.14%	-18.13%	-25.7%	-34.92%	-51.97%	-53.59%	-63.34%	-	-34.44%	9.47%	-15.73%	-	-	-35.71%	-	-
D&A (Non-Cash Add-back)	0	8K	9K	23K	19K	157K	157K	156K	160K	158K	166K	173K	171K	158K	147K	154K	147K	131K	150K	63K
EBIT	-42.18M	-51.57M	-57.41M	-56.01M	-52.71M	-67.89M	-58.82M	-72.49M	-58.58M	-53.72M	-108.46M	-56.86M	-42.06M	-39.17M	-30.72M	-31.31M	-43.24M	-26.55M	-178.13M	-19.53M
Net Interest Income	-885K	-623K	-701K	938K	1.81M	3.07M	4.09M	4.21M	5.27M	6.37M	5.65M	3.84M	3.56M	3.57M	2.29M	784K	86K	0	0	0
Interest Income	935K	1.23M	1.33M	1.69M	1.81M	3.07M	4.09M	4.21M	5.27M	6.37M	5.65M	3.84M	3.56M	3.57M	2.29M	784K	86K	0	0	0
Interest Expense	1.82M	1.85M	2.04M	747K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	-892K	-564K	-970K	945K	1.33M	3.05M	4.1M	4.15M	5.25M	6.35M	-58.36M	3.84M	3.52M	3.54M	2.57M	942K	194K	-422K	103K	-470K
Pretax Income	-43.08M	-53.43M	-59.45M	-56.76M	-52.71M	-67.89M	-58.82M	-72.49M	-58.58M	-53.72M	-108.46M	-53.03M	-38.54M	-35.63M	-28.15M	-30.37M	-43.04M	-26.97M	-178.03M	-20M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	30K	0	0	25K	105K	0	53K	125K	0	268K	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	-0.06%	0%	0%	-0.05%	-0.15%	0%	-0.07%	-0.21%	0%	-0.25%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-43.08M	-53.46M	-59.45M	-56.76M	-52.73M	-67.99M	-58.82M	-72.55M	-58.7M	-53.72M	-108.73M	-53.03M	-38.54M	-35.63M	-28.15M	-30.37M	-43.04M	-26.97M	-178.03M	-20M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	18.3%	21.38%	-1.07%	21.77%	10.17%	-26.57%	45.9%	-36.81%	-52.3%	-50.8%	-286.31%	-	-26.9%	17.23%	-4.36%	-	-	-34.86%	-	-
Net Income (Continuing)	-43.08M	-53.46M	-59.45M	-56.76M	-52.73M	-67.99M	-58.82M	-72.55M	-58.7M	-53.72M	-108.73M	-53.03M	-38.54M	-35.63M	-28.15M	-30.37M	-43.04M	-26.97M	-178.03M	-20M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.23	-0.30	-0.35	-0.35	-0.33	-0.42	-0.37	-0.45	-0.37	-0.34	-0.68	-0.34	-0.25	-0.23	-0.19	-0.20	-0.28	-0.18	-1.17	-0.13
EPS Growth %	30.3%	28.57%	5.41%	22.22%	10.81%	-23.53%	45.59%	-32.35%	-48%	-47.83%	-257.89%	-	-25%	17.86%	-5.56%	-	-	-38.46%	-	-
EPS (Basic)	-0.23	-0.30	-0.35	-0.35	-0.33	-0.42	-0.37	-0.45	-0.37	-0.34	-0.68	-0.34	-0.25	-0.23	-0.19	-0.20	-0.28	-0.18	-1.17	-0.13
Diluted Shares Outstanding	185.16M	179.87M	163.39M	161.84M	161.69M	161.45M	160.98M	159.58M	158.98M	157.94M	158.83M	155.39M	151.95M	151.95M	151.95M	151.95M	151.95M	151.95M	151.95M	151.95M
Basic Shares Outstanding	185.16M	179.87M	163.39M	161.84M	161.69M	161.45M	160.98M	159.58M	158.98M	157.94M	158.83M	155.39M	151.95M	151.95M	151.95M	151.95M	151.95M	151.95M	151.95M	151.95M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-